Polymorphisms ofHLA-DPare associated with response to peginterferon in Caucasian patients with chronic hepatitis B-Reference-Cited by-同舟云学术

Polymorphisms ofHLA-DPare associated with response to peginterferon in Caucasian patients with chronic hepatitis B

Published:2014-08-11 Issue:7 Volume:40 Page:811-818
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Brouwer W. P.¹^ORCID,Sonneveld M. J.¹,Tabak F.²,Simon K.³,Cakaloglu Y.⁴,Akarca U. S.⁵,Zeuzem S.⁶,Ferenci P.⁷,Heathcote J. E.⁸,de Knegt R. J.¹,Boonstra A.¹,Hansen B. E.¹⁹,Janssen H. L. A.¹⁸

Affiliation:

1. Department of Gastroenterology and Hepatology; Erasmus MC University Medical Center; Rotterdam The Netherlands

2. Cerrahpasa Medical Faculty; Istanbul Turkey

3. Division of Infectious Diseases and Hepatology; Wroclaw Medical University; Wroclaw Poland

4. Istanbul Faculty of Medicine; Istanbul Turkey

5. Ege Üniversitesi Tip Fakultesi; Bornova Turkey

6. Medizinische Klinik 1; Klinikum der Johann Wolfgang Goethe-Universität; Frankfurt am Main Germany

7. Medical University of Vienna; Vienna Austria

8. Toronto Center for Liver Disease; Toronto Western and General Hospital; University Health Network; Toronto ON Canada

9. Department of Public Health; Erasmus MC University Medical Center; Rotterdam The Netherlands

Funder

Foundation for Liver and Gastrointestinal research (SLO)

Merck Sharpe & Dohme

Netherlands Genomics Initiative

The VIRGO consortium

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.12910/fullpdf

Reference31 articles.

1. Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon alpha-2b;Buster;Gastroenterology,2008

2. Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial;Janssen;Lancet,2005

3. Sustained response of hepatitis B e antigen-negative patients 3 years after treatment with peginterferon alpha-2a;Marcellin;Gastroenterology,2009

4. Review article: chronic hepatitis B - anti-viral or immunomodulatory therapy?;Rijckborst;Aliment Pharmacol Ther,2011

5. Factors that predict response of patients with hepatitis B e antigen-positive chronic hepatitis B to peginterferon-alfa;Buster;Gastroenterology,2009

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction Model for the Clearance of Hepatitis B Surface Antigen in Patients with Chronic Hepatitis B before Interferon Therapy: A Prospective Case–Control Study;Diagnostics;2024-01-04

2. A novel TRIM22 gene polymorphism promotes the response to PegIFNα therapy through cytokine-cytokine receptor interaction signaling pathway in chronic hepatitis B;Microbiology Spectrum;2023-12-12

3. The effect of HLA-DP gene polymorphisms in Plasmodium Vivax -induced malaria susceptibility;Nucleosides, Nucleotides & Nucleic Acids;2023-11-19

4. An HBV susceptibility variant of KNG1 modulates the therapeutic effects of interferons α and λ1 in HBV infection by promoting MAVS lysosomal degradation;eBioMedicine;2023-08

5. Management and Treatment of Patients with Chronic Hepatitis B: Towards Personalized Medicine;Viruses;2022-03-28